Covalys Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Covalys General Information

Description

Developer of tools for protein research. The company provides protein-labeling products. The company's products help researchers in academic institutions, pharmaceutical and biotech companies to improve the efficiency of research into proteins and their function.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
New England Biolabs
Primary Office
  • Benkenstrasse 254
  • 4108 Witterswil
  • Switzerland
+41 061 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Covalys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 28-Nov-2008 00.000 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Mar-2006 00.000 Completed Startup
2. Early Stage VC (Series B) 01-Feb-2005 $2.59M $4.84M Completed Startup
1. Early Stage VC 16-Oct-2003 $2.25M $2.25M Completed Startup
To view Covalys’s complete valuation and funding history, request access »

Covalys Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BV Group Limited Partner Minority 000 0000 000000 0
Daniel Gutenberg Angel (individual) Minority 000 0000 000000 0
Erfindungs Verwertung Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0
To view Covalys’s complete investors history, request access »